Vaccines, Blood & Biologics
Resources for You
Proper Name: Japanese Encephalitis Vaccine, Inactivated, Adsorbed
Manufacturer: Intercell Biomedical, License # 1790
Approval Date: March 30, 2009
- For the prevention of disease caused by Japanese encephalitis virus in persons 17 years of age and older.
Summary Basis for Regulatory Action - Ixiaro
September 23, 2010
October 14, 2010 Approval Letter - Ixiaro
Efficacy Supplement for Japanese Encephalitis Virus Vaccine, Inactivated, Adsorbed, Pediatric Requirement
October 23, 2009 Approval Letter - Ixiaro
Revisions to the military version of the package insert.
March 30, 2009 Approval Letter
Indication: For the prevention of disease caused by Japanese encephalitis virus in persons 17 years of age and older.
FDA Approves New Vaccine to Prevent Japanese Encephalitis
Press Release: March 30, 2009
Ixiaro - Summary Basis for Regulatory Action Approval History, Letters, Reviews, and Related Documents - Ixiaro Intercell Biomedical